These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24262818)

  • 1. Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial.
    Hollinghurst S; Carroll FE; Abel A; Campbell J; Garland A; Jerrom B; Kessler D; Kuyken W; Morrison J; Ridgway N; Thomas L; Turner K; Williams C; Peters TJ; Lewis G; Wiles N
    Br J Psychiatry; 2014 Jan; 204(1):69-76. PubMed ID: 24262818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.
    Wiles NJ; Thomas L; Turner N; Garfield K; Kounali D; Campbell J; Kessler D; Kuyken W; Lewis G; Morrison J; Williams C; Peters TJ; Hollinghurst S
    Lancet Psychiatry; 2016 Feb; 3(2):137-44. PubMed ID: 26777773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
    Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
    Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial protocol.
    Thomas LJ; Abel A; Ridgway N; Peters T; Kessler D; Hollinghurst S; Turner K; Garland A; Jerrom B; Morrison J; Williams C; Campbell J; Kuyken W; Lewis G; Wiles N
    Contemp Clin Trials; 2012 Mar; 33(2):312-9. PubMed ID: 22101205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial.
    Wiles N; Thomas L; Abel A; Ridgway N; Turner N; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
    Lancet; 2013 Feb; 381(9864):375-84. PubMed ID: 23219570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of computerized cognitive-behavioural therapy for the treatment of depression in primary care: findings from the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial.
    Duarte A; Walker S; Littlewood E; Brabyn S; Hewitt C; Gilbody S; Palmer S
    Psychol Med; 2017 Jul; 47(10):1825-1835. PubMed ID: 28228182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial.
    Hollinghurst S; Peters TJ; Kaur S; Wiles N; Lewis G; Kessler D
    Br J Psychiatry; 2010 Oct; 197(4):297-304. PubMed ID: 20884953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings.
    Sado M; Koreki A; Ninomiya A; Kurata C; Mitsuda D; Sato Y; Kikuchi T; Fujisawa D; Ono Y; Mimura M; Nakagawa A
    Psychiatry Clin Neurosci; 2021 Nov; 75(11):341-350. PubMed ID: 34459077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderators of response to cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care.
    Button KS; Turner N; Campbell J; Kessler D; Kuyken W; Lewis G; Peters TJ; Thomas L; Wiles N
    J Affect Disord; 2015 Mar; 174():272-80. PubMed ID: 25527998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a randomized trial to treat depression among Latinos.
    Kafali N; Cook B; Canino G; Alegria M
    J Ment Health Policy Econ; 2014 Jun; 17(2):41-50. PubMed ID: 25153092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and cost effectiveness of cognitive behavioural therapy plus treatment as usual for the treatment of depression in advanced cancer (CanTalk): study protocol for a randomised controlled trial.
    Serfaty M; King M; Nazareth I; Tookman A; Wood J; Gola A; Aspden T; Mannix K; Davis S; Moorey S; Jones L
    Trials; 2016 Feb; 17(1):113. PubMed ID: 26926910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
    Eveleigh R; Grutters J; Muskens E; Oude Voshaar R; van Weel C; Speckens A; Lucassen P
    Fam Pract; 2014 Oct; 31(5):578-84. PubMed ID: 25121977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.
    Meuldijk D; Carlier IV; van Vliet IM; van Hemert AM; Zitman FG; van den Akker-van Marle ME
    J Ment Health Policy Econ; 2015 Dec; 18(4):175-83. PubMed ID: 26729009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D
    Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.
    Marsden J; Stillwell G; James K; Shearer J; Byford S; Hellier J; Kelleher M; Kelly J; Murphy C; Mitcheson L
    Lancet Psychiatry; 2019 May; 6(5):391-402. PubMed ID: 30952568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of a randomized study of depression treatment options in primary care suggests stepped-care treatment may have economic benefits.
    Yan C; Rittenbach K; Souri S; Silverstone PH
    BMC Psychiatry; 2019 Aug; 19(1):240. PubMed ID: 31382932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.